Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Kringle Pharma, Inc. ( (JP:4884) ) has shared an update.
Kringle Pharma, Inc. reported its financial results for the six months ended March 31, 2025, showing a decline in net sales to 35 million yen and a significant operating loss of 511 million yen. The company’s financial position weakened, with total assets decreasing to 2,290 million yen and a lower equity ratio of 69.2%. Despite these challenges, the company maintains its financial forecast for the fiscal year ending September 30, 2025, without revisions.
More about Kringle Pharma, Inc.
Kringle Pharma, Inc. is a company listed on the Tokyo Stock Exchange, operating in the pharmaceutical industry. The company focuses on developing innovative medical treatments and therapies.
Average Trading Volume: 84,928
Technical Sentiment Signal: Buy
Current Market Cap: Yen5.78B
See more data about 4884 stock on TipRanks’ Stock Analysis page.